Organogenesis Holding (NASDAQ: ORGO) reported Q2 EPS of $0.07, $0.01 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $121.4 million versus the consensus estimate of $120.91 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.